题名 | Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study | 链接 | https://pubmed.ncbi.nlm.nih.gov/37059507/ |
https://pubmed.ncbi.nlm.nih.gov/37059507/ |